JP2011168587A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011168587A5 JP2011168587A5 JP2011026718A JP2011026718A JP2011168587A5 JP 2011168587 A5 JP2011168587 A5 JP 2011168587A5 JP 2011026718 A JP2011026718 A JP 2011026718A JP 2011026718 A JP2011026718 A JP 2011026718A JP 2011168587 A5 JP2011168587 A5 JP 2011168587A5
- Authority
- JP
- Japan
- Prior art keywords
- salt according
- salt
- group
- powder
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 20
- 238000000634 powder X-ray diffraction Methods 0.000 claims 8
- 239000000126 substance Substances 0.000 claims 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 5
- 229910052802 copper Inorganic materials 0.000 claims 5
- 239000010949 copper Substances 0.000 claims 5
- 238000000371 solid-state nuclear magnetic resonance spectroscopy Methods 0.000 claims 5
- 238000001228 spectrum Methods 0.000 claims 5
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 3
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical class C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 claims 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims 2
- HMABYWSNWIZPAG-UHFFFAOYSA-N rucaparib Chemical compound C1=CC(CNC)=CC=C1C(N1)=C2CCNC(=O)C3=C2C1=CC(F)=C3 HMABYWSNWIZPAG-UHFFFAOYSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30427710P | 2010-02-12 | 2010-02-12 | |
| US61/304,277 | 2010-02-12 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015086722A Division JP6013551B2 (ja) | 2010-02-12 | 2015-04-21 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011168587A JP2011168587A (ja) | 2011-09-01 |
| JP2011168587A5 true JP2011168587A5 (enExample) | 2014-02-20 |
| JP5745283B2 JP5745283B2 (ja) | 2015-07-08 |
Family
ID=43859823
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011026718A Active JP5745283B2 (ja) | 2010-02-12 | 2011-02-10 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2015086722A Active JP6013551B2 (ja) | 2010-02-12 | 2015-04-21 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2016183846A Active JP6371350B2 (ja) | 2010-02-12 | 2016-09-21 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2018132270A Active JP6640931B2 (ja) | 2010-02-12 | 2018-07-12 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2019235421A Withdrawn JP2020050671A (ja) | 2010-02-12 | 2019-12-26 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2021078485A Pending JP2021107460A (ja) | 2010-02-12 | 2021-05-06 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015086722A Active JP6013551B2 (ja) | 2010-02-12 | 2015-04-21 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2016183846A Active JP6371350B2 (ja) | 2010-02-12 | 2016-09-21 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2018132270A Active JP6640931B2 (ja) | 2010-02-12 | 2018-07-12 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2019235421A Withdrawn JP2020050671A (ja) | 2010-02-12 | 2019-12-26 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| JP2021078485A Pending JP2021107460A (ja) | 2010-02-12 | 2021-05-06 | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
Country Status (32)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3150610T3 (da) | 2010-02-12 | 2019-11-04 | Pfizer | Salte og polymorfer af 8-fluor-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-on |
| TW201516636A (zh) * | 2013-10-22 | 2015-05-01 | 鴻海精密工業股份有限公司 | 電子裝置及其供電方法 |
| AU2015305696B2 (en) * | 2014-08-22 | 2019-08-29 | Pharma& Schweiz Gmbh | High dosage strength tablets of rucaparib |
| CN109415323A (zh) * | 2016-05-16 | 2019-03-01 | 普尔玛根治疗(哮喘)有限公司 | 喹啉衍生物的结晶 |
| DE102016218772A1 (de) * | 2016-09-28 | 2018-03-29 | Bruker Biospin Gmbh | Verbesserte Temperierung eines NMR-MAS-Rotors |
| EP3573990B1 (en) * | 2017-01-24 | 2024-07-10 | Assia Chemical Industries Ltd. | Solid state forms of rucaparib and of rucaparib salts |
| CN109651377B (zh) * | 2017-10-12 | 2020-10-20 | 成都海创药业有限公司 | 一种治疗癌症的化合物及其用途 |
| CA3080657A1 (en) * | 2017-11-03 | 2019-05-09 | Sandoz Ag | Crystalline salt of a tricyclic poly(adp-ribose) polymerase inhibitor |
| WO2019115000A1 (en) * | 2017-12-15 | 2019-06-20 | Advitech Advisory And Technologies Sa | Process for the preparation of rucaparib and novel synthesis intermediates |
| WO2019130229A1 (en) | 2017-12-28 | 2019-07-04 | Mylan Laboratories Ltd | Methods and intermediates for preparing rucaparib |
| CN111989137A (zh) | 2018-01-05 | 2020-11-24 | 赛博克萨1公司 | 用于治疗涉及酸性或缺氧性患病组织的疾病的化合物、组合物和方法 |
| US10442813B2 (en) | 2018-01-30 | 2019-10-15 | RK Pharma Solutions LLC | Polymorphs of rucaparib camsylate and methods of making same |
| WO2019207596A1 (en) | 2018-04-25 | 2019-10-31 | Mylan Laboratories Limited | Novel crystalline forms of rucaparib (s)-camsylate salt and rucaparib free base |
| WO2019207498A1 (en) * | 2018-04-25 | 2019-10-31 | Biophore India Pharmaceuticals Pvt. Ltd | Solid forms of 8-fluoro-2-{4-[(methylamino)methyl] phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd] indol-6-one ((1s,4r)-7,7dimethyl-2-oxobicyclo [2.2.1] hept-1-yl) methanesulfonic acid salt (rucaparib camsylate) and the prerparation thereof |
| CN108743557A (zh) * | 2018-06-27 | 2018-11-06 | 李莉 | 一种磷酸瑞卡帕布软胶囊及其制备方法 |
| CN109111454A (zh) * | 2018-08-01 | 2019-01-01 | 宁波金未生物科技有限公司 | 一种瑞卡帕布s-樟脑磺酸盐 |
| JP2022510501A (ja) | 2018-10-30 | 2022-01-26 | リペア セラピューティクス インコーポレイテッド | 化合物、医薬組成物、ならびに化合物の調製方法及びａｔｒキナーゼ阻害剤としてのその使用方法 |
| CN111217818A (zh) * | 2018-11-27 | 2020-06-02 | 台耀化学股份有限公司 | 芦卡帕尼樟脑磺酸盐的结晶、及制备三环化合物、芦卡帕尼及其樟脑磺酸盐结晶的方法 |
| WO2020113500A1 (zh) * | 2018-12-06 | 2020-06-11 | 上海诚妙医药科技有限公司 | 芦卡帕利樟脑磺酸盐的新晶型和制备方法及其用途 |
| MX2021006841A (es) | 2018-12-10 | 2021-07-02 | Ideaya Biosciences Inc | Derivados de 2-oxoquinazolina como inhibidores de metionina adenosiltransferasa 2?. |
| KR20220052918A (ko) | 2019-07-10 | 2022-04-28 | 싸이브렉사 2, 인크. | 치료제로서의 사이토톡신의 펩티드 접합체 |
| PH12022550037A1 (en) | 2019-07-10 | 2023-04-12 | Cybrexa 3 Inc | Peptide conjugates of microtubule-targeting agents as therapeutics |
| CN111004244A (zh) * | 2019-12-27 | 2020-04-14 | 重庆市碚圣医药科技股份有限公司 | 一种瑞卡帕布樟脑磺酸盐的合成方法 |
| EP4100125A1 (en) | 2020-02-03 | 2022-12-14 | Sandoz AG | Polymorph of rucaparib mesylate |
| MX2022013258A (es) * | 2020-04-24 | 2022-11-14 | Astrazeneca Ab | Formulaciones farmaceuticas. |
| ES3014370T3 (en) | 2020-04-28 | 2025-04-22 | Rhizen Pharmaceuticals Ag | Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitors |
| EP4178571A4 (en) | 2020-07-10 | 2024-07-17 | The Regents Of The University Of Michigan | GAS41 INHIBITORS AND METHODS OF USE |
| ES3051838T3 (en) | 2020-07-14 | 2025-12-30 | Assia Chem Ind Ltd | Solid state forms of rucaparib salts |
| WO2022090938A1 (en) | 2020-10-31 | 2022-05-05 | Rhizen Pharmaceuticals Ag | Phthalazinone derivatives useful as parp inhibitors |
| TW202304447A (zh) | 2021-04-08 | 2023-02-01 | 瑞士商瑞森製藥公司 | 聚（ａｄｐ－核糖）聚合酶抑制劑 |
| EP4463232A1 (en) | 2022-01-11 | 2024-11-20 | Assia Chemical Industries Ltd. | Solid state forms of rucaparib tosylate |
| WO2023152754A1 (en) * | 2022-02-08 | 2023-08-17 | Sawant, Mohit Manikrao | Crystalline form of rosuvastatin allyl ester |
| WO2024118070A1 (en) * | 2022-11-30 | 2024-06-06 | Ideaya Biosciences, Inc. | 2-oxoquinazoline crystalline forms |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4489011A (en) | 1983-05-16 | 1984-12-18 | Merrell Dow Pharmaceuticals Inc. | Hypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium camsylate salts |
| GB8607683D0 (en) | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
| GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
| GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| DE4125292A1 (de) * | 1991-07-31 | 1993-02-04 | Kali Chemie Pharma Gmbh | 6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993016185A2 (en) | 1992-02-06 | 1993-08-19 | Creative Biomolecules, Inc. | Biosynthetic binding protein for cancer marker |
| US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| JP3053222B2 (ja) | 1995-04-20 | 2000-06-19 | ファイザー・インコーポレーテッド | Ｍｍｐおよびｔｎｆ抑制剤としてのアリールスルホニルヒドロキサム酸誘導体 |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| GB9520822D0 (en) | 1995-10-11 | 1995-12-13 | Wellcome Found | Therapeutically active compounds |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| ATE225343T1 (de) | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
| ES2169355T3 (es) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina. |
| JP3195756B2 (ja) | 1996-07-04 | 2001-08-06 | 公子 吉水 | 潤滑補助体 |
| EP0818442A3 (en) | 1996-07-12 | 1998-12-30 | Pfizer Inc. | Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| EA199900021A1 (ru) | 1996-07-13 | 1999-08-26 | Глаксо, Груп Лимитед | Бициклические гетероароматические соединения в качестве ингибиторов протеинтирозинкиназы |
| DE69716916T2 (de) | 1996-07-13 | 2003-07-03 | Glaxo Group Ltd., Greenford | Kondensierte heterozyklische verbindungen als protein kinase inhibitoren |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| CA2260898C (en) | 1996-07-18 | 2002-05-14 | Pfizer Limited | Phosphinate based inhibitors of matrix metalloproteases |
| PL331895A1 (en) | 1996-08-23 | 1999-08-16 | Pfizer | Arylosulphonylamino derivatives of hydroxamic acid |
| ID18494A (id) | 1996-10-02 | 1998-04-16 | Novartis Ag | Turunan pirazola leburan dan proses pembuatannya |
| DE69730151T2 (de) | 1997-01-06 | 2005-08-04 | Pfizer Inc. | Cyclische sulfonderivate |
| AU721748B2 (en) | 1997-02-03 | 2000-07-13 | Pfizer Products Inc. | Arylsulfonylamino hydroxamic acid derivatives |
| CA2279863A1 (en) | 1997-02-07 | 1998-08-13 | Pfizer Inc. | N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases |
| WO1998034918A1 (en) | 1997-02-11 | 1998-08-13 | Pfizer Inc. | Arylsulfonyl hydroxamic acid derivatives |
| CA2289102A1 (en) | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| JP2002501532A (ja) | 1997-05-30 | 2002-01-15 | メルク エンド カンパニー インコーポレーテッド | 新規血管形成阻害薬 |
| US5835420A (en) | 1997-06-27 | 1998-11-10 | Aplus Flash Technology, Inc. | Node-precise voltage regulation for a MOS memory system |
| ID23668A (id) | 1997-08-08 | 2000-05-11 | Pfizer Prod Inc | Turunan asam ariloksiarilsulfonilamino hidroksamat |
| ATE368665T1 (de) | 1997-08-22 | 2007-08-15 | Astrazeneca Ab | Oxindolylchinazolinderivate als angiogenesehemmer |
| JP2001518470A (ja) | 1997-09-26 | 2001-10-16 | メルク エンド カムパニー インコーポレーテッド | 新規な血管形成阻害剤 |
| WO1999024440A1 (en) | 1997-11-11 | 1999-05-20 | Pfizer Products Inc. | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| GB9725782D0 (en) | 1997-12-05 | 1998-02-04 | Pfizer Ltd | Therapeutic agents |
| RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| GB9800575D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| GB9801690D0 (en) | 1998-01-27 | 1998-03-25 | Pfizer Ltd | Therapeutic agents |
| JP4462654B2 (ja) | 1998-03-26 | 2010-05-12 | ソニー株式会社 | 映像素材選択装置及び映像素材選択方法 |
| PA8469501A1 (es) | 1998-04-10 | 2000-09-29 | Pfizer Prod Inc | Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico |
| PA8469401A1 (es) | 1998-04-10 | 2000-05-24 | Pfizer Prod Inc | Derivados biciclicos del acido hidroxamico |
| IL139934A0 (en) | 1998-05-29 | 2002-02-10 | Sugen Inc | Pyrrole substituted 2-indolinone derivatives and pharmaceutical compositions containing the same |
| UA60365C2 (uk) | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
| DK1004578T3 (da) | 1998-11-05 | 2004-06-28 | Pfizer Prod Inc | 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater |
| US6649645B1 (en) | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
| CN1398189A (zh) | 1998-12-23 | 2003-02-19 | G.D.西尔公司 | 用于治疗肿瘤形成的放疗与cox－2抑制剂的联合治疗 |
| EE05006B1 (et) * | 1999-01-11 | 2008-04-15 | Agouron Pharmaceuticals, Inc. | Polü(ADP-riboos)polümeraaside tritsüklilised inhibiitorid ja neid sisaldavad farmatseutilised kompositsioonid |
| KR100452491B1 (ko) | 2001-03-29 | 2004-10-12 | 한미약품 주식회사 | 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법 |
| KR20040011751A (ko) | 2002-07-30 | 2004-02-11 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| EP1575936A1 (en) † | 2002-12-19 | 2005-09-21 | Pfizer Products Inc. | Complexes of e-2-methoxy-n-(3-{4- [3-methyl-4-(6-methyl- pyridin -3-yloxy)-phenylamino] -quinazolin-6-yl}-allyl)-acetamide, their method of production, and use |
| JP2006522088A (ja) | 2003-03-31 | 2006-09-28 | ファイザー・インク | ポリ（ａｄｐ−リボース）ポリメラーゼの三環系阻害剤の塩 |
| PL1660095T3 (pl) | 2003-07-25 | 2010-07-30 | Cancer Research Tech Ltd | Tricykliczne inhibitory PARP |
| ATE551345T1 (de) † | 2004-09-22 | 2012-04-15 | Pfizer | Polymorphe formen des phosphatsalzes von 8-fluor- 2-ä4-ä(methylamino)methylüphenylü-1,3,4,5- tetrahydro-6h-azepinoä5,4,3-cdüindol-6-on |
| CN101384264B (zh) * | 2004-09-22 | 2012-03-14 | 辉瑞大药厂 | 含有聚（adp-核糖）聚合酶抑制剂的治疗组合物 |
| JP2008513435A (ja) | 2004-09-22 | 2008-05-01 | ファイザー・インク | ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤を含む治療用組成物 |
| PL1794163T3 (pl) | 2004-09-22 | 2010-06-30 | Pfizer | Sposób wytwarzania inhibitorów poli(adp-rybozo)polimerazy |
| GB0502509D0 (en) | 2005-02-07 | 2005-03-16 | Pfizer Ltd | Novel salt form of a dopamine agonist |
| CA2901244A1 (en) * | 2005-02-23 | 2006-08-31 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations of improved content uniformity |
| CN101528202A (zh) * | 2006-07-05 | 2009-09-09 | 特瓦制药工业有限公司 | 美金刚的药物组合物 |
| KR100843401B1 (ko) | 2006-12-04 | 2008-07-04 | 씨제이제일제당 (주) | 결정성 ｓ-(-)-암로디핀 캠실레이트 무수물 및 이의제조방법 |
| JP5495787B2 (ja) * | 2006-12-06 | 2014-05-21 | クオナトウス ファーマシューティカルズ，インコーポレイテッド | （３Ｓ）−３−［Ｎ−（Ｎ’−（２−ｔｅｒｔ−ブチルフェニル）オキサミル）アラニニル］アミノ−５−（２’，３’，５’，６’−テトラフルオロフェノキシ）−４−オキソペンタン酸の結晶形態 |
| WO2008114114A2 (en) * | 2007-03-16 | 2008-09-25 | Pfizer Products Inc. | Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition |
| EP2065385A1 (en) † | 2007-11-28 | 2009-06-03 | Laboratorios SALVAT, S.A. | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester |
| EP2231648A1 (en) * | 2007-12-05 | 2010-09-29 | BIAL - Portela & Ca., S.A. | New salts and crystal forms |
| KR20090060674A (ko) | 2007-12-10 | 2009-06-15 | 씨제이제일제당 (주) | 결정형의 지프라시돈 술폰산염, 그 제조방법, 및 그것를포함하는 약제학적 조성물 |
| NZ586675A (en) † | 2008-01-08 | 2012-04-27 | Merck Sharp & Dohme | Pharmaceutically acceptable salts of 2-{ 4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide |
| SG196833A1 (en) | 2009-01-17 | 2014-02-13 | Boomerang Systems Inc | Variable offset positioning antenna array for enhanced guidance of automated guided vehicles (agvs) |
| DK3150610T3 (da) | 2010-02-12 | 2019-11-04 | Pfizer | Salte og polymorfer af 8-fluor-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-on |
| CN107767647A (zh) | 2011-09-23 | 2018-03-06 | 金泰克斯公司 | 用于后视镜显示的系统和方法 |
| MY165747A (en) | 2011-12-26 | 2018-04-23 | Wintech Polymer Ltd | Polybutylene terephthalate resin pellets, and production method for said polybutylene terephthalate resin pellets |
| US9384339B2 (en) | 2012-01-13 | 2016-07-05 | Telecommunication Systems, Inc. | Authenticating cloud computing enabling secure services |
| US9697529B2 (en) | 2012-03-13 | 2017-07-04 | American Express Travel Related Services Company, Inc. | Systems and methods for tailoring marketing |
| KR101984831B1 (ko) | 2013-01-31 | 2019-05-31 | 삼성전자 주식회사 | 반도체 패키지 및 그 제조 방법 |
| CN103309115B (zh) | 2013-05-30 | 2016-03-23 | 京东方科技集团股份有限公司 | 彩色电泳显示面板及其制造方法、显示装置 |
| US9501163B2 (en) | 2014-05-06 | 2016-11-22 | Symbol Technologies, Llc | Apparatus and method for activating a trigger mechanism |
| US10884952B2 (en) | 2016-09-30 | 2021-01-05 | Intel Corporation | Enforcing memory operand types using protection keys |
| JP6943759B2 (ja) | 2017-12-28 | 2021-10-06 | 株式会社東海理化電機製作所 | シフト装置 |
-
2011
- 2011-02-10 DK DK16183844T patent/DK3150610T3/da active
- 2011-02-10 SI SI201131051T patent/SI2534153T2/sl unknown
- 2011-02-10 RU RU2012138892/04A patent/RU2570198C2/ru active
- 2011-02-10 SM SM20160462T patent/SMT201600462T1/it unknown
- 2011-02-10 AU AU2011213944A patent/AU2011213944B2/en active Active
- 2011-02-10 KR KR1020127023813A patent/KR20120127495A/ko not_active Ceased
- 2011-02-10 CN CN201410818193.1A patent/CN104876937B/zh active Active
- 2011-02-10 PT PT161838446T patent/PT3150610T/pt unknown
- 2011-02-10 PL PL11708094.5T patent/PL2534153T5/pl unknown
- 2011-02-10 PT PT117080945T patent/PT2534153T/pt unknown
- 2011-02-10 BR BR112012019050-4A patent/BR112012019050B1/pt not_active IP Right Cessation
- 2011-02-10 HR HRP20161742TT patent/HRP20161742T4/hr unknown
- 2011-02-10 US US13/522,549 patent/US8754072B2/en active Active
- 2011-02-10 SM SM20190634T patent/SMT201900634T1/it unknown
- 2011-02-10 WO PCT/IB2011/050571 patent/WO2011098971A1/en not_active Ceased
- 2011-02-10 PL PL16183844T patent/PL3150610T3/pl unknown
- 2011-02-10 SG SG10201406805RA patent/SG10201406805RA/en unknown
- 2011-02-10 EP EP19178840.5A patent/EP3597651A1/en not_active Withdrawn
- 2011-02-10 LT LTEP11708094.5T patent/LT2534153T/lt unknown
- 2011-02-10 RS RS20161117A patent/RS55487B2/sr unknown
- 2011-02-10 SG SG2012052171A patent/SG182533A1/en unknown
- 2011-02-10 MX MX2012008911A patent/MX343383B/es active IP Right Grant
- 2011-02-10 HU HUE11708094A patent/HUE030969T4/hu unknown
- 2011-02-10 EP EP16183844.6A patent/EP3150610B1/en active Active
- 2011-02-10 EP EP22199074.0A patent/EP4166558A1/en active Pending
- 2011-02-10 JP JP2011026718A patent/JP5745283B2/ja active Active
- 2011-02-10 LT LT16183844T patent/LT3150610T/lt unknown
- 2011-02-10 CA CA3024216A patent/CA3024216C/en active Active
- 2011-02-10 NZ NZ601445A patent/NZ601445A/en unknown
- 2011-02-10 CA CA2787881A patent/CA2787881C/en active Active
- 2011-02-10 ES ES11708094T patent/ES2607806T5/es active Active
- 2011-02-10 CN CN201180009237.0A patent/CN102884066B/zh active Active
- 2011-02-10 RS RS20191394A patent/RS59494B1/sr unknown
- 2011-02-10 KR KR1020197005968A patent/KR102108226B1/ko active Active
- 2011-02-10 EP EP11708094.5A patent/EP2534153B2/en active Active
- 2011-02-10 ES ES16183844T patent/ES2753748T3/es active Active
- 2011-02-10 SI SI201131808T patent/SI3150610T1/sl unknown
- 2011-02-10 DK DK11708094.5T patent/DK2534153T4/da active
- 2011-02-10 HU HUE16183844A patent/HUE047248T2/hu unknown
- 2011-02-11 TW TW100104676A patent/TWI545123B/zh active
- 2011-02-11 AR ARP110100427A patent/AR080164A1/es not_active Application Discontinuation
-
2012
- 2012-07-12 IL IL220921A patent/IL220921B/en active IP Right Grant
-
2014
- 2014-05-08 US US14/272,589 patent/US9045487B2/en active Active
-
2015
- 2015-04-21 JP JP2015086722A patent/JP6013551B2/ja active Active
- 2015-04-28 US US14/698,463 patent/US9861638B2/en active Active
-
2016
- 2016-09-21 JP JP2016183846A patent/JP6371350B2/ja active Active
- 2016-12-13 CY CY20161101288T patent/CY1118319T1/el unknown
- 2016-12-21 SM SM201600462T patent/SMT201600462B/it unknown
-
2017
- 2017-08-16 AR ARP170102290A patent/AR109356A2/es unknown
- 2017-12-06 US US15/833,073 patent/US10278974B2/en active Active
-
2018
- 2018-07-12 JP JP2018132270A patent/JP6640931B2/ja active Active
- 2018-11-13 CY CY2018031C patent/CY2018031I2/el unknown
- 2018-11-13 LU LU00093C patent/LUC00093I2/fr unknown
- 2018-11-14 HU HUS1800046C patent/HUS1800046I1/hu unknown
- 2018-11-15 LT LTPA2018517C patent/LTC2534153I2/lt unknown
- 2018-11-15 NO NO2018039C patent/NO2018039I1/no unknown
- 2018-11-16 FI FIC20180039C patent/FIC20180039I1/fi unknown
- 2018-11-16 FI FIEP11708094.5T patent/FI2534153T4/fi active
- 2018-11-19 NL NL300958C patent/NL300958I2/nl unknown
- 2018-11-21 FR FR18C1049C patent/FR18C1049I2/fr active Active
-
2019
- 2019-02-28 US US16/288,615 patent/US20200000821A1/en not_active Abandoned
- 2019-10-25 HR HRP20191944TT patent/HRP20191944T1/hr unknown
- 2019-10-31 CY CY20191101132T patent/CY1122218T1/el unknown
- 2019-12-26 JP JP2019235421A patent/JP2020050671A/ja not_active Withdrawn
-
2021
- 2021-05-06 JP JP2021078485A patent/JP2021107460A/ja active Pending